StockData
Dyadic International Inc logo

Dyadic International Inc (DYAI) stock

DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.32+0.00 (+1.30%)

Close on Nov 18, 2026Market cap $11.66MP/E –Yield –

Dyadic International price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Dyadic International's price to sales ratio was 3.7× on Nov 11, 2026, against 10.3× a year earlier. Over the last 5 years it ranged from 0.2× to 44.3×, with a median of 14.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.7×−6.5
2025Dec 31, 202510.2×−5.2
2024Dec 31, 202415.4×−0.3
2023Dec 29, 202315.7×+1.7
2022Dec 30, 202214.0×+13.7
2021Dec 31, 20210.3×−87.3
2020Dec 31, 202087.5×+14.7
2019Dec 31, 201972.9×+2.3
2018Dec 31, 201870.6×–

More Dyadic International figures

See a number that looks wrong?